JOSEPH GERARD GLEESON, M.D.
Neurology at Frost St, San Diego, CA
License number
California G85292
Category
Medical Practice
Type
Pediatrics
License number
California G85292
Category
Neurology
Type
Neurology with Special Qualifications in Child Neurology
Address
Address
8010 Frost St SUITE 510, San Diego, CA 92123
Phone
(858) 966-5819
(858) 309-6303
(858) 309-6301 (Fax)
(858) 309-6303
(858) 309-6301 (Fax)
Personal information
See more information about JOSEPH GERARD GLEESON at radaris.comName
Address
Phone
2050 Pacific Hwy, San Diego, CA 92101
20335 Oxnard St, Woodland Hills, CA 91367
3295 Caminito Eastbluff, La Jolla, CA 92037
5363 Foxhound Way, San Diego, CA 92130
Professional information
Joseph Gerard Gleeson, San Diego CA
Specialties:
Pediatrician
Address:
8010 Frost St, San Diego, CA 92123
3860 Calle Fortunada, San Diego, CA 92123
3860 Calle Fortunada, San Diego, CA 92123
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology with Special Qualification in Child Neurology (Psychiatry and Neurology)
Joseph Gerard Gleeson, San Diego CA
Specialties:
Pediatrics, Neurology, Neurology with Special Qualifications in Child Neurology
Work:
Children's Hospital - San Diego
8010 Frost St, San Diego, CA 92123
8010 Frost St, San Diego, CA 92123
Education:
University of Chicago (1991)
Dr. Joseph G Gleeson, San Diego CA - MD (Doctor of Medicine)
Specialties:
Pediatrics, Pediatric Neurology
Address:
Children's Specialist San Diego
8010 Frost St SUITE 510, San Diego 92123
(858) 966-5819 (Phone)
8010 Frost St SUITE 510, San Diego 92123
(858) 966-5819 (Phone)
Certifications:
Neurology with Special Qualification in Child Neurology, 2007, Pediatrics, 2006
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Children's Specialist San Diego
8010 Frost St SUITE 510, San Diego 92123
Sharp Mary Birch Hospital for Women and Newborns
3003 Health Center Dr, San Diego 92123
8010 Frost St SUITE 510, San Diego 92123
Sharp Mary Birch Hospital for Women and Newborns
3003 Health Center Dr, San Diego 92123
Education:
Medical School
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1991
Children's Hospital
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1991
Children's Hospital
Compositions And Methods For Determining Genetic Polymorphisms In The Tmem216 Gene
US Patent:
2012027, Nov 1, 2012
Filed:
Apr 29, 2011
Appl. No.:
13/098345
Inventors:
Joseph G. GLEESON - San Diego CA, US
Jennifer SILHAVY - San Diego CA, US
Enza Maria VALENTE - Rome, IT
Francesco BRANCATI - Rome, IT
Jennifer SILHAVY - San Diego CA, US
Enza Maria VALENTE - Rome, IT
Francesco BRANCATI - Rome, IT
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
A01K 67/00, C40B 30/00, C12Q 1/68, G01N 33/53, C12N 1/21, C07K 14/47, C07K 16/18, C12N 5/10, C12N 1/19, C12N 15/63, C07H 21/04
US Classification:
800 13, 4353201, 506 7, 435 612, 436501, 435 611, 536 235, 530350, 530324, 5303879, 5303873, 435366, 435325, 435348, 435419, 4352542, 4352523
Abstract:
In alternative embodiments, the invention provides nucleic acid sequences that are genetic polymorphic variations of the human TMEM216 gene, and TMEM216 polypeptide encoded by these variant alleles. In alternative embodiments, the invention provides methods of determining or predicting a predisposition to, or the presence of, a ciliopathy (or any genetic disorder of a cellular cilia or cilia anchoring structure, basal body or ciliary function) in an individual, such as a Joubert Syndrome (JS), a Joubert Syndrome Related Disorder (JSRD) or a Meckel Syndrome (MKS). In alternative embodiments, the invention provides compositions and methods for the identification of genetic polymorphic variations in the human TMEM216 gene, and methods of using the identified genetic polymorphisms and the proteins they encode, e.g., to screen for compounds that can modulate the human TMEM216 gene product, and possibly treat JS, JSRD or MKS. In alternative embodiments, the invention provides cells, cell lines and/or non-human transgenic animals that can be used as screening or model systems for studying ciliopathies and testing various therapeutic approaches in treating ciliopathies, e.g., JS, JSRD or MKS.